These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2037132)

  • 21. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of halothane on transport of 5-hydroxytryptamine by platelet membranes.
    Watkins CA; Mylin LM; Rannels DE
    Biochem J; 1986 Apr; 235(1):33-8. PubMed ID: 3741387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin transporter in rat platelets. Level of protein expression underlies inherited differences in uptake kinetics.
    Hranilović D; Herak-Kramberger CM; Cicin-Sain L; Sabolić I; Jernej B
    Life Sci; 2001 May; 69(1):59-65. PubMed ID: 11411805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinase inhibitors compete with imipramine for binding and inhibition of serotonin transport.
    Helmeste DM; Tang SW
    Eur J Pharmacol; 1994 Apr; 267(2):239-42. PubMed ID: 8050484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
    Segonzac A; Schoemaker H; Tateishi T; Langer SZ
    J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3H]imipramine binding of protein nature in human platelets: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
    Marcusson J; Tiger G
    J Neurochem; 1988 Apr; 50(4):1032-6. PubMed ID: 3279163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets.
    Rehavi M; Ittah Y; Rice KC; Skolnick P; Goodwin FK; Paul SM
    Biochem Biophys Res Commun; 1981 Apr; 99(3):954-9. PubMed ID: 7247951
    [No Abstract]   [Full Text] [Related]  

  • 28. Ligand binding to the serotonin transporter: equilibria, kinetics, and ion dependence.
    Humphreys CJ; Wall SC; Rudnick G
    Biochemistry; 1994 Aug; 33(31):9118-25. PubMed ID: 8049215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of platelet serotonin transport by propranolol.
    Rudnick G; Bencuya R; Nelson PJ; Zito RA
    Mol Pharmacol; 1981 Jul; 20(1):118-23. PubMed ID: 7290078
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
    Kamal LA; Raisman R; Meyer P; Langer SZ
    Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of lectins with human platelet serotonin transporter.
    Helmeste DM; Chudzik J; Tang SW
    Eur J Pharmacol; 1994 Feb; 266(3):327-31. PubMed ID: 8174615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of platelet [3H]-imipramine binding by human plasma protein fractions.
    Strijewski A; Chudzik J; Tang SW
    Life Sci; 1988; 42(16):1543-50. PubMed ID: 3352466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of [3H]imipramine to human platelet membranes with compensation for saturable binding to filters and its implication for binding studies with brain membranes.
    Phillips OM; Wood KM; Williams DC
    J Neurochem; 1984 Aug; 43(2):479-86. PubMed ID: 6330301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
    Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
    J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter.
    Rudnick G; Wall SC
    Mol Pharmacol; 1991 Sep; 40(3):421-6. PubMed ID: 1896028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
    Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.